Parmax Pharma Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 3.34 | 4.33 | 2.54 |
| Operating Expense | 4.86 | 4.52 | 4.12 |
| Net Profit | -0.58 | -0.73 | -2.08 |
| Net Profit Margin | -17.37% | -16.86% | -81.89% |
| Earning Per Share | -1.56 | -1.96 | -5.56 |
| EBIDTA | 0.17 | -0.18 | -1.58 |
| Effective Tax Rate | -0% | -0% | -0% |
Particulars
Mar 2026
Revenue3.34
Operating Expense4.86
Net Profit-0.58
Net Profit Margin-17.37
Earning Per Share-1.56
EBIDTA0.17
Effective Tax Rate-0
